Dacarbazine Suppliers & Bulk Manufacturers
Available Forms: IV Injection
Available Strengths: 100 mg/vial, 200 mg/vial
Reference Brands: DTIC-Dome®(EU & US)
Category:
Oncology Cancer Care
Dacarbazine, branded as DTIC-Dome® (US) and available in generic form, is used to treat malignant melanoma, Hodgkin’s lymphoma, and soft tissue sarcoma. As an alkylating agent, it interferes with DNA replication, preventing cancer cell growth. Available in 100 mg and 200 mg vials for IV injection, Dacarbazine is sourced from GMP-compliant suppliers and is widely used in US and EU markets for oncology treatment.
Dacarbazine is available in IV Injection
and strengths such as 100 mg/vial, 200 mg/vial.
Sourced from GMP-certified and ISO-compliant manufacturers, this API meets
global pharmacopeia standards (USP/EP/JP as applicable). Ideal for pharmaceutical
formulation and commercial manufacturing, Dacarbazine is supplied in
bulk quantities with complete regulatory support including DMF, COA, and MSDS.
|
Technical Specifications & Supply Details
|
| Lead Time |
7 to 60 days (depending on batch size & schedule) |
| MOQ |
As per manufacturer’s batch size |
| COA |
Available with every batch |
| Regulatory Dossier / DMF |
Available upon request |
| Export Documentation |
FSC, COA, Manufacturing License, Product Permission |
| Standards |
IP, BP, USP |
| Certifications |
WHO-GMP, EU-GMP, USFDA (as applicable) |
Dacarbazine can be exported to over 30 countries across Asia, Africa, Europe,
and Latin America. Flexible packaging, competitive pricing, and a verified supplier
network make Pharmatradz a trusted sourcing partner for pharmaceutical companies
and contract manufacturers worldwide.
Product Description:
Dacarbazine, marketed as DTIC-Dome® (by Bristol-Myers Squibb) and available as a generic in the US and EU, is an alkylating agent used in the treatment of malignant melanoma, Hodgkin’s lymphoma, and soft tissue sarcoma. Available in 100 mg and 200 mg vials for IV injection, Dacarbazine interferes with DNA replication, preventing cancer cell division. As a trusted oncology therapy, it is sourced from GMP-compliant suppliers and is a key treatment option for oncologists targeting aggressive cancers. Dacarbazine is widely available in global US and EU markets for hospital and clinic use.
Disclaimer: By continuing to browse, you agree to the terms of use of this website and the Trade Marks displayed, in compliance with the provisions of the Trademark Act, 1999, Section 30 and 30(1) under 'Fair use.'
The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.
Back to Listing